These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8101579)

  • 21. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
    Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
    Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Has the target autoantigen for Graves' ophthalmopathy been found?
    McGregor AM
    Lancet; 1998 Aug; 352(9128):595-6. PubMed ID: 9746018
    [No Abstract]   [Full Text] [Related]  

  • 23. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
    Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
    Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amplification by polymerase chain reaction of immunoglobulin heavy and light chain genes from orbital tissue of patients with Graves' ophthalmopathy.
    McLachlan SM; Prummel MF; Dallow RL; Wiersinga WM; Rapoport B
    Autoimmunity; 1993; 16(2):149-52. PubMed ID: 8180319
    [No Abstract]   [Full Text] [Related]  

  • 25. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.
    Bahn RS; Dutton CM; Natt N; Joba W; Spitzweg C; Heufelder AE
    J Clin Endocrinol Metab; 1998 Mar; 83(3):998-1002. PubMed ID: 9506762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graves' ophthalmopathy.
    Wall JR; Henderson J; Strakosch CR; Joyner DM
    Can Med Assoc J; 1981 Apr; 124(7):855-62, 866. PubMed ID: 7011529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current understanding of pathogenesis of Graves ophthalmopathy].
    Ando T; Eguchi K
    Nihon Rinsho; 2006 Dec; 64(12):2275-8. PubMed ID: 17154091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
    Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
    Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyrotropin receptor antisera for the detection of immunoreactive protein species in retroocular fibroblasts obtained from patients with Graves' ophthalmopathy.
    Burch HB; Sellitti D; Barnes SG; Nagy EV; Bahn RS; Burman KD
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1384-91. PubMed ID: 8200941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenesis of immunogenic hyperthyroidism and endocrine orbitopathy].
    Heufelder AE; Spitzweg C
    Internist (Berl); 1998 Jun; 39(6):599-606. PubMed ID: 9677517
    [No Abstract]   [Full Text] [Related]  

  • 32. Lack of association between a polymorphism in the coding region of the thyrotropin receptor gene and Graves' disease.
    Watson PF; French A; Pickerill AP; McIntosh RS; Weetman AP
    J Clin Endocrinol Metab; 1995 Mar; 80(3):1032-5. PubMed ID: 7883818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 1985 Eastern Section AFCR Young Investigator award. Graves' disease: studies concerning TSH-receptor antibody formation and action.
    Burman KD
    Clin Res; 1986 Sep; 34(3):432-7. PubMed ID: 3757429
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease.
    Bahn RS
    J Clin Endocrinol Metab; 2003 May; 88(5):1939-46. PubMed ID: 12727937
    [No Abstract]   [Full Text] [Related]  

  • 35. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression.
    Salvi M; Vannucchi G; Campi I; Rossi S; Bonara P; Sbrozzi F; Guastella C; Avignone S; Pirola G; Ratiglia R; Beck-Peccoz P
    Eur J Endocrinol; 2006 Apr; 154(4):511-7. PubMed ID: 16556712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts.
    Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS
    J Clin Endocrinol Metab; 2002 May; 87(5):2352-8. PubMed ID: 11994387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
    Baker G; Mazziotti G; von Ruhland C; Ludgate M
    Endocrinology; 2005 Feb; 146(2):835-44. PubMed ID: 15542454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A heritable point mutation in an extracellular domain of the TSH receptor involved in the interaction with Graves' immunoglobulins.
    Bohr UR; Behr M; Loos U
    Biochim Biophys Acta; 1993 Dec; 1216(3):504-8. PubMed ID: 8268237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiomyopathy associated with Graves' disease.
    Koshiyama H; Sellitti DF; Akamizu T; Doi SQ; Takeuchi Y; Inoue D; Sakaguchi H; Takemura G; Sato Y; Takatsu Y; Nakao K
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):111-6. PubMed ID: 8796147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.